Bodhi Tree Biotechnology (BDTB) EBIAT (2024 - 2025)
Bodhi Tree Biotechnology (BDTB) reported EBIAT of -$52948.0 for Q4 2025, up 18.26% year-over-year from -$44772.1 in Q4 2024, and down 395.44% on a QoQ basis from -$10687.0 in Q3 2025.
Bodhi Tree Biotechnology (BDTB) has 2 years of EBIAT data on file, last reported at -$52948.0 in Q4 2025.
- Quarterly EBIAT rose 18.26% year-over-year to -$52948.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$137837.0 (changed N/A YoY) and the FY2025 annual result came in at -$149666.0, down 141.58% from the prior year.
- EBIAT declined to -$52948.0 in Q4 2025 per BDTB's latest filing, from -$10687.0 in the prior quarter.
- Across five years, EBIAT topped out at -$10687.0 in Q3 2025 and bottomed at -$64777.0 in Q4 2024.
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -52,948.00 |
| Sep 30, 2025 | -10,687.00 |
| Jun 30, 2025 | -20,774.00 |
| Mar 31, 2025 | -53,428.00 |
| Dec 31, 2024 | -64,777.00 |